Search

Author/Creator Casado Montero, Luis Felipe

1. Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?. Issue 11 (27th August 2014)

Authors:
García‐Gutiérrez, Valentin; Puerta, Jose Manuel; Maestro, Begoña; Casado Montero, Luis Felipe; Muriel, Alfonso; Molina Hurtado, Jose Ramon; Perez‐Encinas, Manuel; Moreno Romero, Maria Victoria; Suñol, Pere Barba; Sola Garcia, Ricardo; De Paz, Raquel; Ramirez Sanchez, Maria Jose; Osorio, Santiago;...
Journal:
American journal of hematology
Issue:
Volume 89:Issue 11(2014:Nov.)
Page Start:
E206
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma. Issue 3 (3rd June 2020)

Authors:
Alegre, Adrián; de la Rubia, Javier; Sureda Balari, Anna; Encinas Rodríguez, Cristina; Suárez, Alexia; Blanchard, María Jesús; Bargay Lleonart, Joan; Rodríguez-Otero, Paula; Insunza, Andrés; Palomera, Luis; Peñarrubia, María Jesús; Ríos-Tamayo, Rafael; Casado Montero, Luis Felipe; González, Marta...
Journal:
HemaSphere
Issue:
Volume 4:Issue 3(2020)
Page Start:
e380
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search